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Background: Carcinomas occurring at colostomy sites are rare, and most of these are metachronous colorectal
cancers. The median time between colostomy and development of a carcinoma at a colostomy site is 22 years,
which exceeds the length of the recommended follow-up period. We report a rare case of a carcinoma of the trans-
verse colon occurring at a colostomy site in a patient without a history of colorectal cancer.
Case report: An 89-year-old woman presented with a tumor occurring at a colostomy site. Thirty-five years previ-
ously, she had undergone a transverse loop colostomy for an iatrogenic colon perforation that occurred during left
ureteral lithotomy. Upon physical examination, the patient had a hard nodule measuring 3 cm at the colostomy
site. A biopsy of the nodule suggested adenocarcinoma, and the preoperative diagnosis was transverse colon can-
cer. A laparotomy was performed via a peristomal incision with 5-mm skin margins, and the tumor was covered by
a surgical glove to avoid any tumor seeding. The colon was separated from the tumor by 5-cm margins, and the
specimen was removed en bloc. An end colostomy was constructed to a new site on the right side of the abdo-
men. The deficit in the abdominal wall was repaired, and the skin was closed via a purse-string suture. The final
diagnosis of the stoma tumor was transverse colon cancer (T2, N0, M0, stage I). One year and five months after sur-
gery, there was no evidence of recurrence.
Conclusions: The occurrence of carcinomas at colostomy sites in patients without a history of colorectal cancer is
rare. It is important to train ostomates to monitor the stoma for possible tumor recurrence.
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Carcinomas occurring at colostomy sites are rare, with
only 12 cases previously reported in the English litera-
ture (Table 1); most of these are metachronous colorec-
tal cancers. Cases without malignant potential, such as
those involving colorectal cancer or ulcerative colitis, are
very rare. Herein, we describe a case of an 89-year-old
woman who presented with a colostomy tumor 35 years
after undergoing a transverse colostomy for iatrogenic
colon perforation, and we review the literature related to
this malignancy.* Correspondence: maechiyo@hotmail.co.jp
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An 89-year-old Japanese woman with a 1-month history
of stoma bleeding was referred to our hospital. She had
undergone a transverse loop colostomy 35 years previ-
ously for an iatrogenic colon perforation that occurred
during left ureteral lithotomy. Upon physical examin-
ation, the patient was found to have a hard nodule at the
colostomy site, measuring 3 cm (Figure 1). A biopsy of
the nodule suggested adenocarcinoma. Laboratory data
revealed anemia and renal dysfunction. Serum carci-
noembryonic antigen and carbohydrate antigen 19-9
levels were not elevated. Staging computed tomography
showed a 3-cm tumor adjacent to the stoma with no
invasion into the abdominal muscle. There was no evi-
dence of metastatic disease. Colonoscopy via the stoma
revealed no other lesions in the colon or rectum. On the
basis of our findings, the preoperative diagnosis of the
stoma tumor was transverse colon cancer (T2, N0, M0,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Twelve previously reported cases of carcinomas at a stoma site
Author Year Age/sex Past history Term (years) Chief
complaint
Size (cm) Depth Histology Prognosis
Morgan 1966 76/F Ulcerative colitis 31 years after
colostomy
Bleeding 7.4 × 6.4 SI (skin) Adenocarcinoma -
Didolkar 1975 42/F Rectal carcinoma 32 years after
colostomy
Stoma ulcer 3 to 4 - Basal cell carcinoma Alive (2.5 years)
Takami 1983 53/M Rectal carcinoma 19 years after APR Tumor 16 SI (skin) Mod, muc Alive (2 years)
Kusunoki 1996 63/M Ulcerative colitis 6 years after
colostomy
- - MP Mod, muc Alive (5 years)
Shibuya 2002 57/M Rectal carcinoma 8 years after APR Stoma stenosis 6 × 4 SI (skin) Mod Alive (4 years)
Townley 2005 57/F Rectal carcinoma 5 years after APR Tumor 3 Dukes A Adenocarcinoma Alive (6 months)
Papaziogas 2006 77/F Rectal carcinoma 3 months after
Hartmann
Tumor 2.5 - Adenocarcinoma Death (1 year)
Chintamani 2007 30/M Rectal carcinoma 6 years after APR Stoma stenosis - T4N1 Por, sig Death (4 years)
Vijayasekar 2008 61/F Rectal carcinoma 14 years after APR Tumor - SI (subcutaneous) Well -
Okamoto 2009 67/M Rectal carcinoma 15 years after APR Tumor 8 × 10.5 SI (muscle) Well -
Sabater-Marco 2013 61/M Lung/rectal
carcinoma
6 years after APR Tumor - - Large cell carcinoma Death (3 months)
Maurra 2014 75/F Sigmoid volvulus 50 years after
Hartmann
Tumor - SI (muscle) Well, muc Alive (8 years)




Bleeding 3.3 MP Mod Alive (11 months)














Figure 1 Macroscopic findings on admission. The patient had a hard nodule that measured 3 cm at the colostomy site. The arrows indicate
the tumor.
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of the colostomy site were appropriate for this patient.
Although we thought stoma closure was possible, the
patient and her family were opposed to this strategy be-
cause they were concerned about anal function.
Under general anesthesia, a laparotomy was per-
formed via a peristomal incision with 5-mm skin mar-
gins, and the tumor was covered using a surgical glove
to avoid tumor seeding. Adhesion around the stoma
was not strong, and there was no evidence of peritonealFigure 2 Surgical findings. The tumor was removed en bloc.dissemination. Only pericolic lymph nodes were dis-
sected. The colon was separated from the tumor by
5-cm margins, and the specimen was removed en bloc
(Figure 2). An end colostomy was constructed to a new
site on the right side of the abdomen. The deficit in the
abdominal wall was repaired, and the skin was closed
via a purse-string suture. The operative time was 102
min, and blood loss was 52 mL. Macroscopic examin-
ation showed complete excision of the tumor with clear
margins (Figure 3).
Figure 3 Macroscopic findings. Macroscopic examination showed complete excision of the tumor with clear margins.
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Her postoperative course was uneventful, and she
recovered without any complications. One year and
five months after surgery, there is no evidence of
recurrence.
Microscopic examination of the tumor showed moder-
ately differentiated adenocarcinoma mixed with well-
differentiated adenocarcinoma (Figure 4). The tumor
extended into the proper muscle layer and directly in-
vaded the skin. There was no lymph node metastasis.Figure 4 Microscopic findings. Microscopic examination showed moderate
adenocarcinoma.The final diagnosis of the stoma tumor was transverse
colon cancer (T2, N0, M0, stage I).
The study protocol was approved by the ethics commit-
tee of Showa University Northern Yokohama Hospital.
The study was conducted according to the Declaration of
Helsinki.
Discussion
Primary adenocarcinoma arising at a colostomy site is
rare. The first case was reported by Morgan in 1966 [1]ly differentiated adenocarcinoma mixed with well-differentiated
Maeda et al. World Journal of Surgical Oncology  (2015) 13:171 Page 5 of 6and involved a patient whose underlying disease was
ulcerative colitis. The 12 cases reported previously in-
volved patients with metachronous colon cancer (eight
patients), ulcerative colitis (two patients), metachro-
nous lung cancer (one patient) [2], and a sigmoid vol-
vulus (one patient) [3] (Table 1). Malignant potential
was lacking only in the sigmoid volvulus case and in
the case reported here. Cancers arising near stomas
typically show skin metastasis [4] and include meta-
chronous cancers. Immunopathological staining of
cytokeratin facilitates the differential diagnosis [2].
Cutaneous metastasis of colon cancers to operation
scars after cancer resection accounts for 0.6% of cases
of recurrence [5]. The mean interval to the develop-
ment of skin metastasis after colon cancer diagnosis is
4.9 years [6]. The average survival of patients with skin
metastasis is 7.5 months after diagnosis [7], whereas
the median time to the development of a carcinoma at
a colostomy site after the initial operation is 22 years
[8]. Most stoma site carcinomas are diagnosed as ad-
vanced cancers. The Japanese national guidelines [9]
recommend a 5-year follow-up period after colorectal
cancer resection. Thereafter, self-observation of the stoma
by the patient is very important for the early detection of
cancer. In our hospital, nurses who specialize in stoma
care train ostomates in the methods of self-care and self-
observation at the outpatient clinic for several years. The
patient in the case reported here had not received this
training and did not know about the possibility of a
carcinoma arising at the stoma site. It was also difficult for
her to recognize the tumor because it grew slowly over
several years. Thus, it is important to train ostomates in
regard to self-observation of the stoma.
Of the 12 previously reported cases of adenocarcin-
omas arising at colostomies, six involved patients with
T4 colon cancer that invaded the skin or subcutaneous
tissue (pkpk). In the literature, it is not clear whether
tumors directly invade the skin or penetrate the colon
serosa. In the patient described in this report, tumor
invasion included the proper muscle layer, with direct
invasion of the skin. The depth of colostomy site cancer
needs to be clarified in terms of direct invasion or inva-
sion through the colon serosa.
Our patient had no history of cancer, radiation ther-
apy, or ulcerative colitis; the case reported here there-
fore represents an extremely rare case of colostomy site
carcinoma that did not have malignant potential. The
etiology in this case is unclear. The carcinoma may
have resulted from physical stimulation caused by
clothing or unexpected compression, or by chemical
stimulation, such as that resulting from enterobacteria
or bile acids in stools [10]. On the other hand, stoma
site cancers could also occur coincidentally. The inci-
dence of metachronous colorectal cancer afterabdominoperineal resection for rectal cancer is 2.2%
[11]. Most metachronous tumors (51%) are located in
the left hemicolon, as are most stomas after colorectal
cancer. Therefore, in this case, it seems that a colon
cancer occurred coincidentally at the stoma site; how-
ever, physical stimulation or chemical stimulation
could promote their occurrence.
In surgical operations, it is best not to expose the
tumor. Cutaneous recurrence at the stoma closure
suture after 5 years has been reported [12]. In this case,
the tumor was not exposed because it was covered by a
surgical glove. Because surgical site infection is very
common after stoma closure, a purse-string skin closure
[13], which reduces wound infection [14], was per-
formed in this case.
The number of reports describing ileostomy site car-
cinoma is greater than the number of reports describ-
ing colostomy site carcinoma [15]. En bloc resection of
the ileostomy, wide resection of the adjacent anterior
abdominal wall, and transposition of the stoma to a
new site have been shown to provide the best prognosis
for a patient diagnosed with adenocarcinoma following
ileostomy [16].
The mechanism of cancers arising at ileostomy sites is
also speculative. Most grow at the mucocutaneous junc-
tion [17]. Previous reports have proposed that physical
trauma or chemical or physical irritation predisposes
the ileal mucosa to colonic metaplasia, dysplasia, and
malignant change. Although there are many more
colorectal cancer patients than small intestine cancer
patients, there are fewer case reports of colostomy site
carcinomas than ileostomy site carcinomas. The mech-
anism of cancer development at ileostomy sites differs
from that at colostomy sites. Chronic metaplasia and
dysplasia were found in the ileal mucosa adjacent to
tumors in patients with ulcerative colitis and familial
adenomatous polyposis [15], suggesting that the malig-
nant potential might be high in patients with these
underlying diseases.
Conclusions
Primary adenocarcinomas arising at colostomy sites
are rare. Colostomy site carcinomas may occur after
the postoperative follow-up period has ended. In
order to facilitate early detection, it is important to
train ostomates to monitor the stoma for possible
tumors.
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